These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 31784772

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Raloxifene and teriparatide (hPTH 1-34) have complementary effects on the osteopenic skeleton of ovariectomized rats.
    Ma YL, Bryant HU, Zeng Q, Schmidt A, Jee WS, Sato M.
    J Bone Miner Metab; 2005; 23 Suppl():62-8. PubMed ID: 15984416
    [Abstract] [Full Text] [Related]

  • 4. Effect of osteoporosis treatment agents on the cortical bone osteocyte microenvironment in adult estrogen-deficient, osteopenic rats.
    Stern AR, Yao X, Wang Y, Berhe A, Dallas M, Johnson ML, Yao W, Kimmel DB, Lane NE.
    Bone Rep; 2018 Jun; 8():115-124. PubMed ID: 29955630
    [Abstract] [Full Text] [Related]

  • 5. Effects of sequential osteoporosis treatments on trabecular bone in adult rats with low bone mass.
    Amugongo SK, Yao W, Jia J, Lay YA, Dai W, Jiang L, Walsh D, Li CS, Dave NK, Olivera D, Panganiban B, Ritchie RO, Lane NE.
    Osteoporos Int; 2014 Jun; 25(6):1735-50. PubMed ID: 24722767
    [Abstract] [Full Text] [Related]

  • 6. Effect of sequential treatments with alendronate, parathyroid hormone (1-34) and raloxifene on cortical bone mass and strength in ovariectomized rats.
    Amugongo SK, Yao W, Jia J, Dai W, Lay YA, Jiang L, Harvey D, Zimmermann EA, Schaible E, Dave N, Ritchie RO, Kimmel DB, Lane NE.
    Bone; 2014 Oct; 67():257-68. PubMed ID: 25016965
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of genistein aglycone in osteoporotic, ovariectomized rats: a comparison with alendronate, raloxifene and oestradiol.
    Bitto A, Burnett BP, Polito F, Marini H, Levy RM, Armbruster MA, Minutoli L, Di Stefano V, Irrera N, Antoci S, Granese R, Squadrito F, Altavilla D.
    Br J Pharmacol; 2008 Nov; 155(6):896-905. PubMed ID: 18695641
    [Abstract] [Full Text] [Related]

  • 9. Odanacatib Restores Trabecular Bone of Skeletally Mature Female Rabbits With Osteopenia but Induces Brittleness of Cortical Bone: A Comparative Study of the Investigational Drug With PTH, Estrogen, and Alendronate.
    Khan MP, Singh AK, Singh AK, Shrivastava P, Tiwari MC, Nagar GK, Bora HK, Parameswaran V, Sanyal S, Bellare JR, Chattopadhyay N.
    J Bone Miner Res; 2016 Mar; 31(3):615-29. PubMed ID: 26391310
    [Abstract] [Full Text] [Related]

  • 10. Effect of Sequential Treatment with Bisphosphonates After Teriparatide in Ovariectomized Rats: A Direct Comparison Between Risedronate and Alendronate.
    Yano T, Yamada M, Inoue D.
    Calcif Tissue Int; 2017 Jul; 101(1):102-110. PubMed ID: 28337514
    [Abstract] [Full Text] [Related]

  • 11. Increased bone formation and bone mass induced by sclerostin antibody is not affected by pretreatment or cotreatment with alendronate in osteopenic, ovariectomized rats.
    Li X, Ominsky MS, Warmington KS, Niu QT, Asuncion FJ, Barrero M, Dwyer D, Grisanti M, Stolina M, Kostenuik PJ, Simonet WS, Paszty C, Ke HZ.
    Endocrinology; 2011 Sep; 152(9):3312-22. PubMed ID: 21733832
    [Abstract] [Full Text] [Related]

  • 12. The novel non-steroidal selective androgen receptor modulator S-101479 has additive effects with bisphosphonate, selective estrogen receptor modulator, and parathyroid hormone on the bones of osteoporotic female rats.
    Furuya K, Yamamoto N, Ohyabu Y, Makino A, Morikyu T, Ishige H, Kuzutani K, Endo Y.
    Biol Pharm Bull; 2012 Sep; 35(7):1096-104. PubMed ID: 22791158
    [Abstract] [Full Text] [Related]

  • 13. New bone formation with teriparatide [human parathyroid hormone-(1-34)] is not retarded by long-term pretreatment with alendronate, estrogen, or raloxifene in ovariectomized rats.
    Ma YL, Bryant HU, Zeng Q, Schmidt A, Hoover J, Cole HW, Yao W, Jee WS, Sato M.
    Endocrinology; 2003 May; 144(5):2008-15. PubMed ID: 12697709
    [Abstract] [Full Text] [Related]

  • 14. Comparative therapeutic effects of alendronate and alfacalcidol on cancellous and cortical bone mass and mechanical properties in ovariectomized osteopenic rats.
    Iwamoto J, Seki A, Takeda T, Sato Y, Yamada H, Yeh JK.
    J Nutr Sci Vitaminol (Tokyo); 2006 Feb; 52(1):1-8. PubMed ID: 16637224
    [Abstract] [Full Text] [Related]

  • 15. Differing Effects of Parathyroid Hormone, Alendronate, and Odanacatib on Bone Formation and on the Mineralization Process in Intracortical and Endocortical Bone of Ovariectomized Rabbits.
    Vrahnas C, Buenzli PR, Pearson TA, Pennypacker BL, Tobin MJ, Bambery KR, Duong LT, Sims NA.
    Calcif Tissue Int; 2018 Dec; 103(6):625-637. PubMed ID: 30019315
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Bone quality of the newest bone formed after two years of teriparatide therapy in patients who were previously treatment-naïve or on long-term alendronate therapy.
    Hofstetter B, Gamsjaeger S, Varga F, Dobnig H, Stepan JJ, Petto H, Pavo I, Klaushofer K, Paschalis EP.
    Osteoporos Int; 2014 Dec; 25(12):2709-19. PubMed ID: 25037600
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.